The researchers exploit variation in prescribing patterns among VHA primary care providers following the addition of GLP-1s to the VHA formulary in November 2020
Clinical observation, waist circumference, and patient-reported changes across sleep, energy, and recovery give a more complete picture of how the protocol is actually working
The formula is: desired research amount divided by concentration per unit equals units to draw
At week 36, the 12mg group showed the most dramatic eating behavior changes: Perceived hunger decreased by 2.4 points versus placebo Disinhibition improved by 2.6 points Dietary restraint increased by 3.3 points 100% of participants achieved at least 5% body weight loss by week 48 83% achieved 15% or greater weight loss Mean weight reduction reached 24.2% at 48 weeks These numbers represent the strongest weight loss and appetite-related outcomes ever recorded in clinical trials for any GLP-1 class medication
Meanwhile, the beauty industry is positioning products as a way to combat the hollowed look known as Ozempic face. Swiss pharmaceutical company Galderma, Cetaphils parent company, says it has seen growth from its injectables products that compete with Botox